Buyer Class Still Valid In Nifedipine Antitrust Suit

A federal appeals court has decided not to review the class status of a group of direct purchasers that accused Biovail Corp., Elan Corp. PLC and Teva Pharmaceuticals Ltd. of conspiring...

Already a subscriber? Click here to view full article